Teen Boy with a Progressive Pruritic Rash

News
Poll

VIDEO: The lesions appear oval with trailing edge scale. Note the the pattern and distribution in the video interview; what's your diagnosis?

A 13 y/o boy is seen for a pruritic rash that been spreading x1 week; lesions are widespread over chest and back w axilla involvement. Recent hx of viral illness now resolved. PMH: noncontributory.

 

What is your diagnosis?

A. Pityriasis rosea
B. Tinea corporis (ringworm)
C. Eczema
D. Psoriasis
E. Viral exanthem

Newsletter

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!
Related Content
Evommune Launches Phase 2b Trial of Oral MRGPRX2 Antagonist, EVO756, In Adults With Atopic Dermatitis / image credit atopic dermatitis ©designua/stock.adobe.com

Evommune Launches Phase 2b Trial of Oral MRGPRX2 Antagonist, EVO756, In Adults With Atopic Dermatitis

Grace Halsey
September 1st 2025
Article
2025 AAD Atopic Dermatitis Update: Linda Stein Gold, MD, on New Topical and Biologic Therapies

2025 AAD Atopic Dermatitis Update: Linda Stein Gold, MD, on New Topical and Biologic Therapies

Linda Stein Gold, MD;Sydney Jennings
September 1st 2025
Podcast
Investigational Oral IL-23 Receptor Antagonist Improves Skin Clearance in Psoriasis: Daily Dose / image credit: ©New Africa/AdobeStock

Investigational Oral IL-23 Receptor Antagonist Improves Skin Clearance in Psoriasis: Daily Dose

Sydney Jennings
September 1st 2025
Article
The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression

The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression

Sydney Jennings
September 1st 2025
Podcast
nt Improvements in Hidradenitis Suppurativa Observed During Treatment with GLP-1 Receptor Agonists / image credit ©syahrir/stock.adobe.com

Improvements in Hidradenitis Suppurativa Observed During Treatment with GLP-1 Receptor Agonists

Grace Halsey
September 1st 2025
Article
Investigational Oral IL-23 Receptor Antagonist Icotrokinra Improves Skin Clearance in Psoriasis in Phase 3 Study / image credit Robert Bissonnette, MD, International Eczema Council

Investigational Oral IL-23 Receptor Antagonist Icotrokinra Improves Skin Clearance in Psoriasis in Phase 3 Study

Grace Halsey
September 1st 2025
Article
© 2025 MJH Life Sciences

All rights reserved.